Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan

Chisaki, Y; Nakano, H; Minamide, J; Yano, Y

Chisaki, Y (通讯作者)，Kyoto Pharmaceut Univ, Educ & Res Ctr Clin Pharm, 5-Nakauchi Cho,Yamashina Ku, Kyoto 6078414, Japan.

CLINICAL DRUG INVESTIGATION, 2023; 43 (11): 839

Abstract

Background and ObjectivesAtezolizumab has demonstrated safety and efficacy in patients with metastatic non-small cell lung cancer (NSCLC) in the IMpow......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索